Literature DB >> 31741989

Association Between Dose and Duration of Cisplatin Exposure with Cytotoxicity Effect on Nasopharyngeal Carcinoma Stem Cell.

Laksmi Kusuma Wardhani1, Widodo Ario Kentjono1, Achmad Chusnu Romdhoni1.   

Abstract

Nasopharyngeal carcinoma (NPC) is ranked 6th of malignant tumors in Indonesia. To analyze the correlation of dose and duration of cisplatin exposure with cytotoxic effects on nasopharyngeal carcinoma stem cells. The biopsy NPC tissue was cultured and processed to obtain NPC stem cells to be treated with cisplatin different doses and durations (24 and 48 h). The number of dead cells after exposure will be calculated using a hemocytometer. Death stem cell density of NPC at exposure of 2 μg/ml cisplatin dose was 81.37%, while the smallest death cell density a dose of 0.05 μg/ml after a 72-h observation was 21.3%. The coefficient correlation 0.827 and value p = 0.000 (p < 0.05). The analysis of the correlation between cisplatin exposure duration and death cell was also significant with the correlation coefficient - 0.357 and the value p = 0.001 (p < 0.05). There was a correlation between the increased dose of cisplatin with the cytotoxicity effects on NPC stem cell. © Association of Otolaryngologists of India 2018.

Entities:  

Keywords:  Cisplatin; Cytotoxicity; Dose; Duration of exposure; Nasopharyngeal carcinoma (NPC)

Year:  2018        PMID: 31741989      PMCID: PMC6848681          DOI: 10.1007/s12070-018-1317-4

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  20 in total

1.  Comparison of cisplatin and carboplatin cytotoxicity in human ovarian cancer cell lines using the MTT assay.

Authors:  J Fanning; W C Biddle; M Goldrosen; K Crickard; U Crickard; M S Piver; K A Foon
Journal:  Gynecol Oncol       Date:  1990-11       Impact factor: 5.482

Review 2.  Biochemical mechanisms of cisplatin cytotoxicity.

Authors:  Victoria Cepeda; Miguel A Fuertes; Josefina Castilla; Carlos Alonso; Celia Quevedo; Jose M Pérez
Journal:  Anticancer Agents Med Chem       Date:  2007-01       Impact factor: 2.505

Review 3.  The shape of cell death.

Authors:  M Leist; P Nicotera
Journal:  Biochem Biophys Res Commun       Date:  1997-07-09       Impact factor: 3.575

4.  Effects of prolonged exposure to cisplatin on cytotoxicity and intracellular drug concentration.

Authors:  V Troger; J L Fischel; P Formento; J Gioanni; G Milano
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

5.  In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells.

Authors:  C P Saris; P J van de Vaart; R C Rietbroek; F A Blommaert
Journal:  Carcinogenesis       Date:  1996-12       Impact factor: 4.944

6.  Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.

Authors:  Norazizah Shafee; Christopher R Smith; Shuanzeng Wei; Yoon Kim; Gordon B Mills; Gabriel N Hortobagyi; Eric J Stanbridge; Eva Y-H P Lee
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

7.  Cancer stem cells in head and neck squamous cell carcinoma.

Authors:  Marcus M Monroe; Eric C Anderson; Daniel R Clayburgh; Melissa H Wong
Journal:  J Oncol       Date:  2010-11-08       Impact factor: 4.375

8.  Stress response inhibits the nephrotoxicity of cisplatin.

Authors:  Marie H Hanigan; Mei Deng; Lei Zhang; Peyton T Taylor; Maia G Lapus
Journal:  Am J Physiol Renal Physiol       Date:  2004-09-07

9.  Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation.

Authors:  Marlinda Adham; Antonius N Kurniawan; Arina Ika Muhtadi; Averdi Roezin; Bambang Hermani; Soehartati Gondhowiardjo; I Bing Tan; Jaap M Middeldorp
Journal:  Chin J Cancer       Date:  2012-02-07

10.  Computational modeling of apoptotic signaling pathways induced by cisplatin.

Authors:  Ji-Young Hong; Geun-Hong Kim; Jun-Woo Kim; Soon-Sung Kwon; Eisuke F Sato; Kwang-Hyun Cho; Eun Bo Shim
Journal:  BMC Syst Biol       Date:  2012-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.